Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial

Authors :: Derks, M.G.M. Bastiaannet, E. van de Water, W. de Glas, N.A. Seynaeve, C. Putter, H. Nortier, J.W.R. Rea, D. Hasenburg, A. Markopoulos, C. Dirix, L.Y. Portielje, J.E.A. van de Velde, C.J.H. Liefers, G.J.
Publication Year :: 2018
Abstract: Aim: Due to increasing life expectancy, patients with breast cancer remain at risk of dying due to breast cancer over a long time. This study aims to assess the impact of age on breast cancer mortality and other cause mortality 10 years after diagnosis. Methods: Postmenopausal patients with hormone-receptor positive breast cancer were included in the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial between 2001 and 2006. Age at diagnosis was categorised as

Tools